U.S. Markets closed

Amicus Therapeutics, Inc. :FOLD-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017

CapitalCube
Capital Cube
Amicus Therapeutics, Inc. :FOLD-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017

Categories: Yahoo FinanceGet free summary analysis Amicus Therapeutics, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Amicus Therapeutics, Inc. – Protalix Biotherapeutics, Inc., Biogen Inc., BioMarin Pharmaceutical Inc., Esperion Therapeutics, Inc., GlaxoSmithKline plc Sponsored ADR, Shire PLC Sponsored ADR, Novo Nordisk A/S Sponsored ADR ... Read more (Read more...)